Who
Thomas McCauley
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Stoke Therapeutics; Chief Scientific Officer, Omega Therapeutics.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 9 Mar 2022
- Last trade
- 15 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jul 2026filed 17 Jul 2026 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 7 Feb 2024filed 9 Feb 2024 | Omega Therapeuticsoption or derivative | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 7 Feb 2024filed 9 Feb 2024 | Omega Therapeuticsoption or derivative | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 28 Feb 2023filed 2 Mar 2023 | Omega Therapeuticsoption or derivative | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 27 Oct 2022filed 28 Oct 2022 | Omega Therapeuticsoption or derivative | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 9 Mar 2022filed 11 Mar 2022 | Omega Therapeuticsoption or derivative | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.